Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Fish Litigation Blog

Welcome to the Fish & Richardson litigation blog where our intellectual property attorneys share information on nationwide litigation developments and trends.

Fish Litigation Blog
Filter blogs by
Webinars

Fish Litigation Blog

The depth and breadth of Fish’s litigation practice is constantly expanding to fit the needs of our clients and the realities of the economic, business, and technological challenges they face. Our litigation blog reflects the full expanse of our litigation practice. Among other things, we discuss: developments in patent and trademark litigation, intricacies associated with ITC proceeding, Federal Circuit and Supreme Court decisions, the rapidly evolving life sciences industry, the Delaware Court of Chancery, and other important issues


IP Litigation, Life Sciences
June 26, 2020
First Circuit Finds Device Patent Improperly Listed in the Orange Book
Authors: Kayleigh E. McGlynn, Brian D. Coggio
IP Litigation, Life Sciences
June 4, 2020
Generic Drug Labeling and Induced Patent Infringement
Authors: Karrie Wheatley, Ph.D., Brian D. Coggio, Geoffrey D. Biegler
Life Sciences, IP Law Essentials
May 12, 2020
Prodrugs – Federal Circuit Holds That A PTE Does Not Cover Their Metabolites
Author: Brian D. Coggio
IP Litigation, Federal Circuit, Life Sciences
April 10, 2020
Keeping Up With Life Sciences Appeals: 1Q2020
Authors: Ryan V. Petty, Veena V. Tripathi, Betsy Flanagan
IP Litigation, Federal Circuit, Life Sciences
April 2, 2020
Section 101: Cert. Denied … Now What?
Authors: Jonathan E. Singer, Betsy Flanagan, Deanna J. Reichel
IP Litigation, Life Sciences
March 24, 2020
Federal Circuit Holds Life Sciences Claims Eligible in Illumina v. Ariosa
Author: Betsy Flanagan
Life Sciences
March 20, 2020
Insulin and Other Biological Products Previously Regulated as “Drugs” Transition to Biologics Regulation on March 23, 2020
Authors: Cheryl Wang, Jenny Shmuel, Ph.D., Michael A. Anderson, Ph.D.
Life Sciences
February 7, 2020
Increasing Competition in the Biologic Market Through Truthful Advertising
Authors: Cheryl Wang, Jenny Shmuel, Ph.D.
Life Sciences
January 31, 2020
White Paper | Biosimilars - 2019 Year in Review
Authors: Felix A. Eyzaguirre, Philip K. Chen, Jenny Shmuel, Ph.D.
IP Litigation, Life Sciences
January 7, 2020
California Law on Reverse Payment Settlements Goes into Effect
Author: DJ Healey
IP Litigation, Life Sciences
December 16, 2019
The Doctrine of Equivalents in BPCIA Litigation
Authors: Kayleigh E. McGlynn, Tracea L. Rice, Jenny Shmuel, Ph.D.
load more posts